The Food and Drug Administration on Monday expanded approval of Johnson & Johnson's prostate cancer pill Zytiga for men with an earlier stage of the disease.
News | Business, Atlanta Journal-Constitution: Business
Mon, 12/10/2012 - 1:07pm
The Food and Drug Administration on Monday expanded approval of Johnson & Johnson's prostate cancer pill Zytiga for men with an earlier stage of the disease.